Scientific Reports vs PLOS ONE: An Honest Comparison for 2026

One metric most comparison guides skip: long-term citation accumulation. According to bibliometric data, PLOS ONE papers tend to accumulate more citations over a 5-year window (8-12 citations on average) compared to Scientific Reports papers (3-5 citations after 5 years). This matters if your career evaluation weighs total citations rather than journal IF.

The reason: PLOS ONE's biology and biomedicine community cites more actively over longer periods. Physical science papers in Scientific Reports often get cited quickly but plateau earlier.

• Your field has stronger recognition for Scientific Reports (physical sciences, earth sciences, engineering)
• You want the Nature Portfolio brand association through Springer Nature
• Your institution has a Springer Nature read-and-publish agreement that reduces or eliminates the $2,850 APC
• You need faster first decisions (Scientific Reports has reduced its backlog recently)
• Your promotion criteria include hard IF floors (IF > 3.0 or > 4.0)

• Your field traditionally publishes in PLOS ONE (biology, biomedicine, public health)
• APC budget matters ($1,895 vs $2,850 saves $955 per paper)
• You value CC-BY open access and strict data sharing mandates
• Your funders mandate PLOS-level OA compliance (common with Wellcome Trust, Gates Foundation)
• You want stronger long-term citation accumulation in your field

The megajournal model emerged because journals like Nature and Cell were (and still are) rejecting technically sound research purely on novelty or perceived significance. That left a lot of valid science without a home. PLOS ONE created the template in 2006: if your methods are rigorous and your data supports your conclusions, we'll publish it.

Scientific Reports copied that model five years later, with Springer Nature's institutional weight behind it.

The practical consequence: both journals publish enormous volume. Your paper sits in a pool of thousands of annual publications. Discovery happens primarily through search and citation, not through anyone browsing the journal.

Scientific Reports peaked at around 4.5 a few years back. It's now at 3.9, per JCR 2024 data. PLOS ONE peaked in 2010 at 4.4 and has been falling since, now at 2.6.

This is structural, not a sign that quality has dropped. Both journals publish so much content that citation dilution is inevitable. Most published papers in any megajournal receive few citations. A handful receive many. The average stays low.

For most researchers, a 3.9 vs 2.6 difference doesn't matter for career evaluation. What matters is whether the journal is indexed, respected in your field, and whether the paper will be discoverable. Both clear that bar.

Where it does matter: if you're in a field with quantitative promotion criteria tied to journal IF thresholds, check what your institution uses. According to data from European and Asian academic surveys, roughly 40% of departments in those regions have hard IF floors (IF > 3.0 or IF > 4.0) that could make the difference here.

The Springer Nature brand isn't irrelevant. Scientific Reports benefits from publisher infrastructure that gives it higher library coverage, better metadata standards, and stronger SEO across academic search engines. Papers published in Scientific Reports tend to show up higher in Google Scholar searches for their topic area.

It's a marginal advantage, but in a volume-driven publishing environment, discoverability matters.

Scientific Reports also has a slightly stronger presence in physical sciences, earth and environmental sciences, and engineering compared to PLOS ONE. If your field isn't primarily biology or medicine, Scientific Reports is often where more of your peers publish.

PLOS ONE has a decade's head start and a cleaner institutional reputation. PLOS is an open-access nonprofit, and that matters to some research communities, particularly in public health, global health, and fields with strong OA values. The PLOS brand communicates something that Springer Nature (a commercial publisher) doesn't.

PLOS ONE also has higher name recognition outside the academic world. Science journalists know PLOS ONE. Policy audiences know PLOS ONE. If any part of your work touches public audiences or media coverage, PLOS ONE has a slight edge in brand recognition.

For biological and biomedical sciences, PLOS ONE has historically been stronger in author community and citation density. More biologists publish there, so more biologists read it.

In our pre-submission review work with manuscripts targeting Scientific Reports and PLOS ONE, we notice three patterns that consistently separate accepted papers from rejected ones across both journals.

Statistical reporting that doesn't match the study design. We find this in roughly 35% of manuscripts we review for either journal. At more selective journals, papers with weak statistics get desk-rejected before anyone examines the methods closely. At Scientific Reports and PLOS ONE, they go to review, and reviewers catch exactly those problems. In practice, soundness-review journal reviewers function as the last quality gate, which means they're often more methodologically rigorous than reviewers at higher-IF journals who evaluate significance first.

The "Nature brand confusion" framing mistake. This sinks papers at Scientific Reports specifically. Authors frame their cover letters and abstracts as if they're submitting to a Nature-branded selective journal, emphasizing novelty and impact claims. Scientific Reports editors don't evaluate those criteria. What they evaluate is rigor, reproducibility, and whether your conclusions follow from your data. Papers that reframe around methodological strength consistently outperform papers that don't.

Incomplete ethics and data availability statements. We see this derail submissions at PLOS ONE more than at Scientific Reports. PLOS ONE's data sharing mandates are stricter, and editors routinely desk-reject papers with vague "data available on request" language. According to PLOS ONE's submission guidelines, all data must be deposited in a public repository or included as supplementary files. This catches roughly 15% of otherwise publishable papers.

Before submitting to either journal, a Scientific Reports vs PLOS ONE fit check can identify statistical reporting gaps, missing ethics documentation, and framing issues that trigger rejection even at soundness-review venues.

For biology and biomedicine: lean toward PLOS ONE unless you have a Springer Nature institutional agreement that reduces the APC.

For physical sciences, earth science, and engineering: Scientific Reports is the more natural community.

For everything else: pick based on where your collaborators publish and where your target audience reads. Don't pick either as a first-choice target if there's a realistic chance your paper belongs at a more selective venue.

Is Scientific Reports better than PLOS ONE?

Neither is definitively better. Scientific Reports has a higher impact factor (3.9 vs 2.6, per JCR 2024) and stronger discoverability in physical sciences. PLOS ONE has a stronger reputation in biology and biomedicine and better brand recognition with non-academic audiences. The right choice depends on your field.

Do reviewers at Scientific Reports and PLOS ONE check for novelty?

No. Both journals use technical soundness as their primary publication criterion. Reviewers check whether your methods are sound and your conclusions follow from your data. They don't assess whether the findings are novel or significant enough. That's a deliberate design choice, not a quality problem.

Is Scientific Reports indexed in PubMed?

Yes. Scientific Reports is indexed in PubMed/MEDLINE. So is PLOS ONE. Both are indexed in Web of Science and Scopus. Indexing is not a differentiator between these two journals.

Are megajournal publications respected by hiring committees?

It depends on the field and institution. In biomedical sciences, a paper in Scientific Reports or PLOS ONE is respected as a legitimate publication but carries less weight than a paper in a high-impact specialty journal. For early-career researchers who need publications, both are completely appropriate venues.

What is the difference in APC between Scientific Reports and PLOS ONE?

Scientific Reports charges approximately $2,850 per article. PLOS ONE charges $1,895. That's a $955 difference per paper. However, many institutions have Springer Nature read-and-publish agreements that can reduce or eliminate the Scientific Reports APC.

Which journal has faster review times?

Both journals have comparable review timelines of roughly 3 to 5 months from submission to first decision. SciRev community data shows median first decision at about 14 weeks for both. Neither offers a genuinely fast-track option.